BeyondSpring Inc. Long-Term Debt, Maturity, Year Two
BeyondSpring Inc. (BYSI) had Long-Term Debt, Maturity, Year Two of $2.16 million as of 2021-03-31, per its 6-K filed 2021-06-16.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2021-06-16
- 2021-03-31: Long-Term Debt, Maturity, Year Two $2.16M.
- 2020-12-31: Long-Term Debt, Maturity, Year Two $2.17M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2021-03-31 | $2.16M 6-K · filed 2021-06-16 |
| 2020-12-31 | $2.17M 20-F · filed 2021-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |